Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice

INTRODUCTION: Trimetazidine (TMZ) was shown to reduce angina symptoms and increase the exercise capacity in stable angina (SA) patients. A new formulation allowing a once-daily (od) dosage could improve patients’ satisfaction and adherence. METHODS: ODA was a 3-month, observational, multicenter, pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Glezer, Maria G., Vygodin, Vladimir A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133142/
https://www.ncbi.nlm.nih.gov/pubmed/30105656
http://dx.doi.org/10.1007/s12325-018-0756-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133142/
https://www.ncbi.nlm.nih.gov/pubmed/30105656
http://dx.doi.org/10.1007/s12325-018-0756-3

Ejemplares similares